Batey, Sharyn R.
GlaxoSmithKline (United States)
3 papers on CoChat
Most cited papers
- Verified
A Prospective Safety Surveillance Study for Bupropion Sustained-Release in the Treatment of Depression
Dunner, D. L., Zisook, S., Billow, A. A., Batey, S. R., Johnston, J. A., & Ascher, J. A. (1998) · The Journal of Clinical Psychiatry
Treatment of Major DepressionPharmacovigilance and Adverse Drug Reactions
Cited by 180
- Verified
Bupropion Sustained Release Versus Paroxetine for the Treatment of Depression in the Elderly
Weihs, K. L., Settle, E. C., Batey, S. R., Houser, T. L., Donahue, R. M. J., & Ascher, J. A. (2000) · The Journal of Clinical Psychiatry
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 150
- Verified
Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression
Weihs, K. L., Houser, T. L., Batey, S. R., Ascher, J. A., Bolden-Watson, C., Donahue, R. M. J., & Metz, A. (2002) · Biological Psychiatry
Treatment of Major DepressionBipolar Disorder and Treatment
Cited by 65
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free